CD8A and neoplasm: In B16-F10 tumor-bearing animals, THOR-707 administration drove the marked expansion of CD8+ T and NK cells within tumor and spleen tissues without stimulation of Treg expansion (Fig. 5 and Supplementary Figs. 9, 14 and 15).